| 1 |
Struys MM, De Smet T, Glen JI, et al. The history of target-controlled infusion [J]. Anesth Analg, 2016, 122(1): 56-69.
|
| 2 |
Zhang L, Wang H, Li Q, et al. Big data and medical research in China [J]. BMJ, 2018, 360: j5910.
|
| 3 |
Farag E, Westlake B, Dutton RP, et al. The ASA committee for neuroanesthesia and anesthesia quality institute: report for demographic patterns for neurosurgical anesthesia practice in the United States [J]. J Neurosurg Anesthesiol, 2018, 30(2): 189-191.
|
| 4 |
Leopold JA. Precision medicine based on personal phenotyping [J]. Trends Cardiovasc Med, 2023, 27: S1050-1738(23)00016-6.
|
| 5 |
Feehley T, O'Donnell CW, Mendlein J, et al. Drugging the epigenome in the age of precision medicine [J]. Clin Epigenetics, 2023, 15(1): 6.
|
| 6 |
Engbers FHM, Dahan A. Anomalies in target-controlled infusion: an analysis after 20 years of clinical use [J]. Anaesthesia, 2018, 73(5): 619-630.
|
| 7 |
Liu N, Le Guen M, Benabbes-Lambert F, et al. Feasibility of closed-loop titration of propofol and remifentanil guided by the spectral M-Entropy Monitor [J]. Anesthesiology, 2012, 116(2): 286-295.
|
| 8 |
Martín-Mateos I, Méndez Pérez JA, Reboso Morales JA, et al. Adaptive pharmacokinetic and pharmacodynamic modelling to predict propofol effect using BIS-guided anesthesia [J]. Comput Biol Med, 2016, 75: 173-180.
|
| 9 |
Fang M, Tao Y, Wang Y. An enriched simulation environment for evaluation of closed-loop anesthesia [J]. J Clin Monit Comput, 2014, 28(1): 13-26.
|
| 10 |
Hemmerling TM, Arbeid E, Wehbe M, et al. Evaluation of a novel closed-loop total intravenous anaesthesia drug delivery system: a randomized controlled trial [J]. Br J Anaesth, 2013, 110(6): 1031-1039.
|
| 11 |
杨宁, 杨明, 彭文平, 等. BIS指导下异丙酚闭环与开环靶控输注腹部手术麻醉效果的比较 [J]. 中南大学学报·医学版, 2020, 45(12): 1419-1424.
|
| 12 |
Kuizenga MH1, Vereecke HE, Struys MM. Model-based drug administration: current status of target-controlled infusion and closed-loop control [J]. Curr Opin Anaesthesiol, 2016, 29(4): 475-481.
|
| 13 |
Hemmerling TM, Charabati S, Salhab E, et al. The Analgoscore: a novel score to monitor intraoperative nociception and its use for closed-loop application of remifentanil [J]. J Comput, 2009, 4: 311-318.
|
| 14 |
Bibian S, Dumont GA, Black I. Closed-loop target-controlled infusion systems: stability and performance aspects [J]. Mil Med, 2015, 180(3 Suppl): 96-103.
|
| 15 |
吴奇伟, 岳云, 张忱. 腹部手术中闭环与开环靶控输注罗库溴铵的药效比较 [J/OL]. 中华临床医师杂志(电子版), 2012, 6(6): 1605-1606.
|
| 16 |
Dussaussoy C, Peres M, Jaoul V, et al. Automated titration of propofol and remifentanil decreases the anesthesiologist's workload during vascular or thoracic surgery: a randomized prospective study [J]. J Clin Monit Comput, 2014, 28(1): 35-40.
|
| 17 |
Guo Y, Wang D, Yang X, et al. Effects of different sufentanil target concentrations on the MACBAR of sevoflurane inpatients with carbon dioxide pneumoperitoneum stimulus [J]. BMC Anesthesiol, 2020, 20(1): 239.
|
| 18 |
赵艳, 王玉洁, 邱维吉, 等. 静吸复合全麻时靶控输注低浓度舒芬太尼的准确性评价 [J]. 中华麻醉学杂志, 2020, 40(8): 4.
|
| 19 |
韩灵, 庞磊, 连鑫等. 不同效应室靶浓度舒芬太尼对丙泊酚意识消失EC50的影响 [J/OL]. 中华临床医师杂志(电子版), 2011, 5(06): 1601-1605.
|
| 20 |
Chen L, Wang M, Xiang H, et al. Prediction of effect-site concentration of sufentanil by dose-response target controlled infusion of sufentanil and propofol for analgesic and sedation maintenance in burn dressing changes [J]. Burns, 2014, 40(3): 455-459.
|
| 21 |
李柳旬, 徐波, 吴宗泽, 等. NI指导下丙泊酚-瑞芬太尼程控性闭环靶控输注麻醉用于腹腔镜胆囊切除术的效果 [J]. 中华麻醉学杂志, 2016, 36(12): 1423-1427.
|
| 22 |
Mahr N, Bouhake Y, Chopard G, et al. Postoperative neurocognitive disorders after closed-loop versus manual target controlled-infusion of propofol and remifentanil in patients undergoing elective major noncardiac surgery: the randomized controlled postoperative cognitive dysfunction-electroencephalographic-guided anesthetic administration trial [J]. Anesth Analg, 2021, 133(4): 837-847.
|
| 23 |
Hüppe T, Maurer F, Sessler DI, et al. Retrospective comparison of Eleveld, Marsh, and Schnider propofol pharmacokinetic models in 50 patients [J]. Br J Anaesth, 2020, 124(2): e22-e24.
|
| 24 |
Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers[J]. Anesthesiology, 1998, 88(5): 1170-1182.
|
| 25 |
Schüttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study [J]. Anesthesiology, 2000, 92(3): 727-738.
|
| 26 |
陈广民, 郭雷, 李恩有. 丙泊酚靶控输注准确性的研究进展 [J]. 中国现代应用药学, 2020, 37(19): 5.
|
| 27 |
Anderson BJ, Bagshaw O. Practicalities of total intravenous anesthesia and target-controlled infusion in children [J]. Anesthesiology, 2019, 131(1): 164-185.
|
| 28 |
Eleveld DJ, Colin P, Absalom AR, et al. Target-controlled-infusion models for remifentanil dosing consistent with approved recommendations [J]. Br J Anaesth, 2020, 125(4): 483-491.
|
| 29 |
Maitre PO, Ausems ME, Vozeh S, et al. Evaluating the accuracy of using population pharmacokinetic data to predict plasma concentrations of alfentanil [J]. Anesthesiology, 1988, 68: 59-67.
|
| 30 |
Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation [J]. J Pharmacol Exp Ther, 1987, 240: 159-166.
|
| 31 |
Wu W, Zhou Y, Zhu Y, et al. Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study [J]. BMJ Open, 2022, 12(8): e058662.
|
| 32 |
Ingrande J, Lemmens HJ. Target-Controlled Infusion: not a one-sized-fits-all answer to drug administration [J]. Anesth Analg, 2018, 127(4): 813-814.
|
| 33 |
Glen JB, White M. A comparison of the predictive performance of three pharmacokinetic models for propofol using measured values obtained during target-controlled infusion [J]. Anaesthesia, 2014, 69(6): 550-557.
|
| 34 |
de la Fuente NF, Puga VA, Cortínez LI, et al. The effective effect-site propofol concentration for induction in morbidly obese patients using total body weight with a new pharmacokinetic model [J]. Anesth Analg, 2013, 117(1): 283-284.
|
| 35 |
Chidambaran V, Venkatasubramanian R, Sadhasivam S, et al. Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents [J]. Paediatr Anaesth, 2015, 25(9): 911-923.
|
| 36 |
Cortínez LI, De la Fuente N, Eleveld DJ, et al. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis [J]. Anesth Analg, 2014, 119(2): 302-310.
|
| 37 |
Eleveld DJ. Target-controlled-infusion for special populations: How different is different enough? [J]. Acta Anaesthesiol Scand, 2019, 63(4): 422-423.
|
| 38 |
Short TG, Hannam JA, Laurent S, et al. Refining target-controlled infusion: an assessment of pharmacodynamic target-controlled infusion of propofol and remifentanil using a response surface model of their combined effects on bispectral index [J]. Anesth Analg, 2016, 122(1): 90-97.
|
| 39 |
陈杭. 麻醉靶控输注的控制策略及算法研究 [D]. 杭州: 浙江大学, 2007.
|
| 40 |
王乐, 夏彬彬, 陈世财. 生理药代动力学模型在临床合理用药中的应用 [J]. 中国临床药理学杂志, 2023, 39(01): 127-130.
|
| 41 |
Deepika D, Kumar V. The role of “physiologically based pharmacokinetic model (PBPK)” new approach methodology (NAM) in pharmaceuticals and environmental chemical risk assessment [J]. Int J Environ Res Public Health, 2023, 20(4): 3473.
|
| 42 |
Fairman K, Choi MK, Gonnabathula P, et al. An overview of physiologically-based pharmacokinetic models for forensic science [J]. Toxics, 2023, 11(2): 126.
|
| 43 |
Hartmanshenn C, Scherholz M, Androulakis IP. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine [J]. J Pharmacokinet Pharmacodyn, 2016, 43(5): 481-504.
|
| 44 |
姜晓峰. 医疗大数据在临床医学中的应用现状 [J/OL]. 中华临床医师杂志(电子版), 2018, 12(8): 427-431.
|